Literature DB >> 29377124

Purinergic signaling in oligodendrocyte development and function.

Taylor G Welsh1, Sarah Kucenas1,2.   

Abstract

Myelin, an insulating membrane that enables rapid action potential propagation, is an essential component of an efficient, functional vertebrate nervous system. Oligodendrocytes, the myelinating glia of the central nervous system (CNS), produce myelin throughout the CNS, which requires continuous proliferation, migration, and differentiation of oligodendrocyte progenitor cells. Because myelination is essential for efficient neurotransmission, researchers hypothesize that neuronal signals may regulate the cascade of events necessary for this process. The ability of oligodendrocytes and oligodendrocyte progenitor cells to detect and respond to neuronal activity is becoming increasingly appreciated, although the specific signals involved are still a matter of debate. Recent evidence from multiple studies points to purinergic signaling as a potential regulator of oligodendrocyte development and differentiation. Adenosine triphosphate (ATP) and its derivatives are potent signaling ligands with receptors expressed on many populations of cells in the nervous system, including cells of the oligodendrocyte lineage. Release of ATP into the extracellular space can initiate a multitude of signaling events, and these downstream signals are specific to the particular purinergic receptor (or receptors) expressed, and whether enzymes are present to hydrolyze ATP to its derivatives adenosine diphosphate and adenosine, each of which can activate their own unique downstream signaling cascades. This review will introduce purinergic signaling in the CNS and discuss evidence for its effects on oligodendrocyte proliferation, differentiation, and myelination. We will review sources of extracellular purines in the nervous system and how changes in purinergic receptor expression may be coupled to oligodendrocyte differentiation. We will also briefly discuss purinergic signaling in injury and diseases of the CNS.
© 2018 International Society for Neurochemistry.

Entities:  

Keywords:  ATP; glia; myelin; oligodendrocyte; purine; purinergic receptors

Mesh:

Substances:

Year:  2018        PMID: 29377124      PMCID: PMC5937939          DOI: 10.1111/jnc.14315

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  103 in total

Review 1.  Structure and function of adenosine receptors and their genes.

Authors:  B B Fredholm; G Arslan; L Halldner; B Kull; G Schulte; W Wasserman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2000-11       Impact factor: 3.000

Review 2.  Medicinal chemistry of adenosine, P2Y and P2X receptors.

Authors:  Kenneth A Jacobson; Christa E Müller
Journal:  Neuropharmacology       Date:  2015-12-12       Impact factor: 5.250

3.  Exacerbation of experimental autoimmune encephalomyelitis in P2X7R-/- mice: evidence for loss of apoptotic activity in lymphocytes.

Authors:  Lanfen Chen; Celia F Brosnan
Journal:  J Immunol       Date:  2006-03-01       Impact factor: 5.422

4.  P2Y12 receptor expression is a critical determinant of functional responsiveness to ATX's MORFO domain.

Authors:  Jameel Dennis; Magdalena K Morgan; Martin R Graf; Babette Fuss
Journal:  Purinergic Signal       Date:  2011-12-04       Impact factor: 3.765

5.  P2X7 receptors mediate ischemic damage to oligodendrocytes.

Authors:  Maria Domercq; Alberto Perez-Samartin; David Aparicio; Elena Alberdi; Olatz Pampliega; Carlos Matute
Journal:  Glia       Date:  2010-04-15       Impact factor: 7.452

6.  Gain-of-function of P2X7 receptor gene variants in multiple sclerosis.

Authors:  Olatz Oyanguren-Desez; Alfredo Rodríguez-Antigüedad; Pablo Villoslada; María Domercq; Elena Alberdi; Carlos Matute
Journal:  Cell Calcium       Date:  2011-09-08       Impact factor: 6.817

7.  P2X7 receptors and Fyn kinase mediate ATP-induced oligodendrocyte progenitor cell migration.

Authors:  Ji-Feng Feng; Xiao-Fei Gao; Ying-Yan Pu; Geoffrey Burnstock; Zhenghua Xiang; Cheng He
Journal:  Purinergic Signal       Date:  2015-06-23       Impact factor: 3.765

Review 8.  Phosphodiesterase-Ialpha/autotaxin (PD-Ialpha/ATX): a multifunctional protein involved in central nervous system development and disease.

Authors:  Jameel Dennis; Luciana Nogaroli; Babette Fuss
Journal:  J Neurosci Res       Date:  2005-12-15       Impact factor: 4.164

9.  Downregulation of P2X7 receptor expression in rat oligodendrocyte precursor cells after hypoxia ischemia.

Authors:  Li-Yan Wang; Wen-Qin Cai; Peng-Hui Chen; Qi-Yue Deng; Cong-Min Zhao
Journal:  Glia       Date:  2009-02       Impact factor: 7.452

10.  Adenosine A1 receptor agonist, N6-cyclohexyladenosine, protects myelin and induces remyelination in an experimental model of rat optic chiasm demyelination; electrophysiological and histopathological studies.

Authors:  Ali Akbar Asghari; Mahnaz Azarnia; Javad Mirnajafi-Zadeh; Mohammad Javan
Journal:  J Neurol Sci       Date:  2012-12-20       Impact factor: 3.181

View more
  8 in total

1.  PPAR-γ activation enhances myelination and neurological recovery in premature rabbits with intraventricular hemorrhage.

Authors:  Sunil Krishna; Bokun Cheng; Deep R Sharma; Sunita Yadav; Erin S Stempinski; Sahil Mamtani; Elisa Shah; Anjali Deo; Trishna Acherjee; Teena Thomas; Xusheng Zhang; Jinghang Zhang; Dumitru A Iacobas; Praveen Ballabh
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-07       Impact factor: 11.205

Review 2.  Therapeutic Potential of Astrocyte Purinergic Signalling in Epilepsy and Multiple Sclerosis.

Authors:  Paola Nobili; Weida Shen; Katarina Milicevic; Jelena Bogdanovic Pristov; Etienne Audinat; Ljiljana Nikolic
Journal:  Front Pharmacol       Date:  2022-05-02       Impact factor: 5.988

Review 3.  Glial Purinergic Signaling in Neurodegeneration.

Authors:  Marie J Pietrowski; Amr Ahmed Gabr; Stanislav Kozlov; David Blum; Annett Halle; Kevin Carvalho
Journal:  Front Neurol       Date:  2021-05-14       Impact factor: 4.003

4.  Reappraisal of Human HOG and MO3.13 Cell Lines as a Model to Study Oligodendrocyte Functioning.

Authors:  Kim M A De Kleijn; Wieteke A Zuure; Jolien Peijnenborg; Josje M Heuvelmans; Gerard J M Martens
Journal:  Cells       Date:  2019-09-17       Impact factor: 6.600

Review 5.  Applying hiPSCs and Biomaterials Towards an Understanding and Treatment of Traumatic Brain Injury.

Authors:  María Lacalle-Aurioles; Camille Cassel de Camps; Cornelia E Zorca; Lenore K Beitel; Thomas M Durcan
Journal:  Front Cell Neurosci       Date:  2020-11-12       Impact factor: 5.505

6.  Integrated bioinformatics analysis identifies the effects of Sema3A/NRP1 signaling in oligodendrocytes after spinal cord injury in rats.

Authors:  Rong Hu; Mengting Shi; Haipeng Xu; Xingying Wu; Kelin He; Yi Chen; Lei Wu; Ruijie Ma
Journal:  PeerJ       Date:  2022-08-16       Impact factor: 3.061

Review 7.  Motor Exit Point (MEP) Glia: Novel Myelinating Glia That Bridge CNS and PNS Myelin.

Authors:  Laura Fontenas; Sarah Kucenas
Journal:  Front Cell Neurosci       Date:  2018-10-02       Impact factor: 5.505

Review 8.  Ion Channels as New Attractive Targets to Improve Re-Myelination Processes in the Brain.

Authors:  Federica Cherchi; Irene Bulli; Martina Venturini; Anna Maria Pugliese; Elisabetta Coppi
Journal:  Int J Mol Sci       Date:  2021-07-06       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.